China Medical GatewayLoading your healthcare gateway…

Li Jun Ling

Li Jun Ling — Chief Physician — Medical Oncology — Medical Academy Cancer Hospital

Specialties

Mainly engaged in the medical treatment of lung cancer, including chemotherapy, targeted therapy, and immunotherapy. Skilled in addressing specific clinical problems and advocates comprehensive care for patients undergoing lung cancer treatment.

Education

Studied at the Medical Department of Ningxia Medical College from 1978 to 1983, and obtained a Doctor of Clinical Medicine degree from Peking Union Medical College in 2012.

Professional Experience

Chief Physician of Internal Medicine, Professor, and Doctor of Medicine at the Cancer Hospital of the Chinese Academy of Medical Sciences, and doctoral supervisor at the Graduate School of Peking Union Medical College. After graduation, mainly engaged in clinical internal medicine work. Worked successively at Alxa Left Banner Hospital in Inner Mongolia, Sanhe County Hospital in Hebei, Jiuxianqiao Hospital in Beijing, and Fuxing Hospital in Beijing. Since 1990, has been engaged in oncology internal medicine work, and from 1993 to 1994, underwent advanced training in the Department of Internal Medicine at the Cancer Hospital of the Chinese Academy of Medical Sciences, after which transferred to work at the hospital and has been there since. From 1994 to 1997, followed Professor Chu Datong and mainly engaged in biological therapy and chemoimmunotherapy for tumors. Since 1998, participated in the internal medicine lung group under the guidance of Professor Zhang Xiangru. In 2004, obtained the qualification of chief physician. In 2006, obtained a Master’s degree in Clinical Medicine from Peking Union Medical College, supervised by Professor Zhang Xiangru. From April 2005 to April 2006, underwent advanced training in the Department of Oncology at the Johns Hopkins Singapore International Medical Center, carrying out clinical oncology work under the guidance of Professor Alex Chang. Promoted to chief physician in 2010. In 2012, obtained a Doctoral degree in Clinical Medicine from Peking Union Medical College, under the supervision of Professor Shi Yuankai. In 2013, was appointed as a doctoral supervisor at the Graduate School of Peking Union Medical College. Since 2004, has been a member of the American Society of Clinical Oncology (ASCO), and is currently a member of the International Association for the Study of Lung Cancer (IASLC) and the European Society for Medical Oncology (ESMO). In 2011, was selected as one of the first Beijing Health Science Popularization Experts. From June 2016 to June 2018, served as the Deputy Director of Huanxing Cancer Hospital, dispatched from the Cancer Hospital of the Chinese Academy of Medical Sciences. From June to November 2018, worked at the Shenzhen Hospital and Nanshan Cancer Center of the Cancer Hospital of the Chinese Academy of Medical Sciences.

Professional Roles

First Chairman of the Translational Medicine Subcommittee of the Beijing Tumor Prevention and Treatment Society; Deputy Secretary-General of the Chinese Geriatric Oncology Society (CGOS) and Deputy Chairman of the Lung Cancer Subcommittee; Deputy General Director and Executive Director of the 4th Committee of the Geriatric Oncology Branch of the Chinese Society of Gerontology and Geriatrics; Standing Committee Member of the Adverse Drug Reaction Management Subcommittee of the Beijing Tumor Prevention and Treatment Research Society; Member of the American Society of Clinical Oncology (ASCO); Member of the European Society for Medical Oncology (ESMO); Member of the International Association for the Study of Lung Cancer (IASLC); one of the first health science popularization experts in Beijing; 2021 “Pass on Humanistic Feelings, Forge Medical Warmth” Top Ten Medical Humanities Innovation Experts; Review Editor for Frontiers in Oncology and Frontiers in Pharmacology; Reviewer for journals including Frontiers in Immunology and Cancer Management and Research

Return to Home